Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,22 USD | -1,77% | -5,13% | +73,44% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 145 mln. 136 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -33 mln. -30,85 mln. | Nettowinst (verlies) 2025 * | -46 mln. -43 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | 94,2 mln. 88,05 mln. | Nettoliquiditeiten 2025 * | 50,8 mln. 47,48 mln. | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-4,37
x | K/w-verhouding 2025 * |
-3,64
x | Werknemers | 30 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 95,99% |
Recentste transcriptie over Regulus Therapeutics Inc.
1 dag | -1,77% | ||
1 week | -5,13% | ||
Lopende maand | -22,92% | ||
1 maand | -17,32% | ||
3 maanden | +77,60% | ||
6 maanden | +70,77% | ||
Lopend jaar | +73,44% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Hagan
CEO | Chief Executive Officer | 55 | 04-01-16 |
Preston Klassen
PSD | President | 55 | 22-06-23 |
Crispina Calsada
DFI | Director of Finance/CFO | 54 | 30-08-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Pascale Witz
BRD | Director/Board Member | 57 | 01-06-17 |
David Baltimore
BRD | Director/Board Member | 86 | 01-01-09 |
Director/Board Member | 75 | 01-04-13 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 2,22 | -1,77% | 91 807 |
23-04-24 | 2,26 | +2,73% | 101 587 |
22-04-24 | 2,2 | +3,29% | 127 753 |
19-04-24 | 2,13 | -4,05% | 222 754 |
18-04-24 | 2,22 | -5,13% | 202 895 |
uitgestelde koers Nasdaq, 24 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+73,44% | 145 mln. | |
-1,51% | 104 mld. | |
+3,22% | 97,42 mld. | |
+1,31% | 22,2 mld. | |
-16,53% | 21,23 mld. | |
-9,84% | 18,33 mld. | |
-42,33% | 16,35 mld. | |
-20,09% | 15,06 mld. | |
+5,47% | 13,98 mld. | |
+28,85% | 11,66 mld. |